Epoqe Pharma ApS — Credit Rating and Financial Key Figures
CVR number: 42443670
Nordre Fasanvej 215, 2000 Frederiksberg
tel: 26343323
www.epoqepharma.com
Income statement (kDKK)
2021 | 2022 | 2023 | |
|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 |
| Net sales | |||
| Gross profit | -17.07 | -19.35 | 1 273.17 |
| Employee benefit expenses | -1 445.96 | ||
| EBIT | -17.07 | -19.35 | - 172.79 |
| Other financial expenses | -0.96 | -0.43 | -1.46 |
| Pre-tax profit | -18.03 | -19.78 | - 174.25 |
| Income taxes | 4.35 | 38.34 | |
| Net earnings | -18.03 | -15.43 | - 135.92 |
Assets (kDKK)
2021 | 2022 | 2023 | |
|---|---|---|---|
| Intangible assets total | |||
| Tangible assets total | |||
| Investments total | |||
| Long term receivables total | |||
| Inventories total | |||
| Prepayments and accrued income | 0.14 | ||
| Current other receivables | 16.46 | 80.44 | |
| Current deferred tax assets | 4.35 | 42.69 | |
| Short term receivables total | 20.81 | 123.27 | |
| Cash and bank deposits | 145.08 | 2 558.76 | 987.80 |
| Cash and cash equivalents | 145.08 | 2 558.76 | 987.80 |
| Balance sheet total (assets) | 145.08 | 2 579.56 | 1 111.06 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | |
|---|---|---|---|
| Share capital | 88.89 | 88.89 | 88.89 |
| Retained earnings | 62.22 | 44.19 | 28.76 |
| Profit of the financial year | -18.03 | -15.43 | - 135.92 |
| Shareholders equity total | 133.08 | 117.65 | -18.27 |
| Non-current accruals and deferred income | 2 443.41 | 859.80 | |
| Non-current liabilities total | 2 443.41 | 859.80 | |
| Current trade creditors | 100.71 | ||
| Other non-interest bearing current liabilities | 12.00 | 18.50 | 168.82 |
| Current liabilities total | 12.00 | 18.50 | 269.53 |
| Balance sheet total (liabilities) | 145.08 | 2 579.56 | 1 111.06 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.